Latest Dimerix (ASX:DXB) News
Page 2
Page 2 of 5
Dimerix Charts Growth with $1.9 Billion Licensing Pipeline and New Kidney Drug
6 Aug 2026
Healthcare Wrap - Week 31 (27 July -> 31 July) 2026
1 Aug 2026
Dimerix Secures Fifth Licensing Deal and Expands Pipeline with DMX-652 Acquisition
30 July 2026
Market Wrap - Week 30 (20 July -> 24 July) 2026
25 July 2026
Healthcare Wrap - Week 30 (20 July -> 24 July) 2026
25 July 2026
Dimerix Secures Extended US Patent for DMX-652 Ahead of Phase 2 AKI Trial
23 July 2026
Market Wrap - Week 29 (13 July -> 17 July) 2026
18 July 2026
Healthcare Wrap - Week 29 (13 July -> 17 July) 2026
18 July 2026
Dimerix Bolsters Kidney Disease Pipeline with Phase 2-Ready AKI Drug DMX-652 Acquisition
17 July 2026
Healthcare Wrap - Week 28 (6 July -> 10 July) 2026
11 July 2026
Dimerix Opens Post-Trial Access to DMX-200 for FSGS Patients
9 July 2026
Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026
2 May 2026